These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15430420)

  • 1. Methylandrostenediol: a non-virilizing derivative of testosterone in metastatic cancer of the breast.
    HOMBURGER F; KASDON SC; FISHMAN WH
    Proc Soc Exp Biol Med; 1950 May; 74(1):162-4. PubMed ID: 15430420
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal therapy in cancer of the breast. II. Effect of methylandrostenediol on clinical course and hormonal excretion.
    SEGALOFF A; GORDON D; HORWITT BN; SCHLOSSER JV; MURISON PJ
    Cancer; 1952 Mar; 5(2):271-4. PubMed ID: 14905410
    [No Abstract]   [Full Text] [Related]  

  • 3. Methylandrostenediol in palliative treatment of breast cancer.
    KASDON SC; FISHMAN WH; DART RM; BONNER CD; HOMBURGER F
    J Am Med Assoc; 1952 Apr; 148(14):1212-6. PubMed ID: 14907362
    [No Abstract]   [Full Text] [Related]  

  • 4. Complications of testosterone therapy in the female; the use of methylandrostenediol as a substitute.
    ROBINSON WW
    Q Rev Surg; 1953 Sep; 10(3):163-5. PubMed ID: 13100620
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylandrostenediol, a non-virilizing steroid hormone with testosterone-like effects.
    HOMBURGER F; KASDON SC; FISHMAN WH
    J Clin Invest; 1950 Jun; 29(6):823. PubMed ID: 15436758
    [No Abstract]   [Full Text] [Related]  

  • 6. Some metabolic and biochemical effects of methylandrostenediol.
    HOMBURGER F; DART RM; BONNER CD; BRANCHE G; KASDON SC; FISHMAN WH
    J Clin Endocrinol Metab; 1953 Jun; 13(6):704-11. PubMed ID: 13061589
    [No Abstract]   [Full Text] [Related]  

  • 7. Complications of testosterone therapy in the female; the use of methylandrostenediol as a substitute.
    ROBINSON WW
    West J Surg Obstet Gynecol; 1953 Feb; 61(2):79-82. PubMed ID: 13029453
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of local changes in connective tissue induced by testosterone propionate, dehydroepiandrosterone, methylandrostenediol and cholesterol].
    RUBENS-DUVAL A; VILLIAUMEY J
    Ann Endocrinol (Paris); 1956 Oct; 17(5):637-41. PubMed ID: 13411661
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of myotrophic and androgenic activities of 19-nortestosterone cyclopentylpropionate, androstanolone, and methylandrostenediol.
    BARNES LE; STAFFORD RO; GUILD ME; OLSON KJ
    Proc Soc Exp Biol Med; 1954 Oct; 87(1):35-8. PubMed ID: 13224668
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of a new methylandrostenediol derivative (methylandrostenediol 3-propionate) on protein anabolism].
    MASSONS JM
    Rev Iber Endocrinol; 1955; 2(10):421-32. PubMed ID: 13290275
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in the vaginal smear in rats treated with testosterone propionate and methylandrostenediol].
    BERLINGIERI D
    Arch Ostet Ginecol; 1959; 64():938-55. PubMed ID: 13799559
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylandrostenediol; a protein-anabolic steroid with little androgenic activity.
    GORDAN GS; EISENBERG E; MOON HD; SAKAMOTO W
    J Clin Endocrinol Metab; 1951 Feb; 11(2):209-12. PubMed ID: 14814201
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methylandrostenediol and its use in therapy of premenstrual mastalgia].
    ELIAS COSTA J; GUGLIELMONE P
    Obstet Ginecol Lat Am; 1955 Aug; 13(8):333-4. PubMed ID: 13280219
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methylandrostenediol and its application in the treatment of premenstrual mastodynia].
    COSTA JE; GUGLIELMONE P
    Sem Med; 1955 Oct; 107(16):872-3. PubMed ID: 13281582
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of prednisone with methylandrostenediol in advanced uterine cancer].
    PESCETTO G
    Minerva Ginecol; 1956 Jul; 8(13):552-6. PubMed ID: 13378150
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in adrenal cortex function after methylandrostenediol therapy of uterine cancer].
    FERABOLI M
    Minerva Ginecol; 1955 Jun; 7(12):124-5. PubMed ID: 13253323
    [No Abstract]   [Full Text] [Related]  

  • 17. [A contribution to the use of androgens in gynecology with reference to methylandrostenediol].
    SCHLOSSER W
    Munch Med Wochenschr; 1953 Mar; 95(12):343-6. PubMed ID: 13072372
    [No Abstract]   [Full Text] [Related]  

  • 18. [Androgenic effect of methylandrostenediol in animal experiment].
    ABT KR
    Gynaecologia; 1953 Apr; 135(4):214-7. PubMed ID: 13068672
    [No Abstract]   [Full Text] [Related]  

  • 19. Methylandrostenediol.
    HENDERSON E; WEINBERG M
    J Clin Endocrinol Metab; 1951 Jun; 11(6):641-52. PubMed ID: 14841252
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methylandrostenediol, its properties].
    ROBERT J
    Sem Hop; 1953 Feb; 29(9):423-6. PubMed ID: 13076263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.